Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2025-09-24 Regulatory Filings
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release from CARMAT providing an update on its ongoing receivership procedure, the status of a takeover bid, and the suspension of its share trading on Euronext. While it discusses potential liquidation and delisting, it is primarily an announcement regarding corporate restructuring and financial status during a receivership. It does not fit the specific criteria for a formal delisting notice (which would be a regulatory filing confirming the removal) or a simple report publication announcement. Given the focus on the receivership, takeover bid, and capital structure implications, it falls under the 'Capital/Financing Update' category as it pertains to the company's survival and financial restructuring.
2025-09-24 English
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release issued by CARMAT regarding an update on its ongoing receivership procedure and the resumption of share trading. It details the status of a takeover bid, the court hearing, and the financial implications for shareholders and creditors. While it discusses potential liquidation and delisting, it is primarily a corporate announcement regarding the company's current operational and legal status. It does not fit the specific criteria for a standalone audit report, proxy statement, or financial report, and is best classified as a regulatory filing/announcement.
2025-08-20 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release from CARMAT regarding the status of its ongoing judicial reorganization (redressement judiciaire) and the resumption of stock trading. It provides updates on the bidding process, the potential for liquidation, and the financial status of the company. It does not fit into specific categories like 10-K, Earnings Release, or M&A, but rather serves as a general regulatory announcement regarding the company's operational and legal status. Therefore, it is classified as a Regulatory Filing (RNS).
2025-08-20 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release from CARMAT regarding an update on its receivership procedure and the suspension of its share trading on Euronext. It details the status of a takeover bid and the upcoming court hearing. This falls under the category of a regulatory announcement regarding the company's financial and operational status, specifically related to its legal and market standing, which is best classified as a Regulatory Filing (RNS) as it does not fit into specific categories like M&A (which usually implies a completed or definitive agreement) or Legal Proceedings (which usually refers to litigation).
2025-08-13 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release from CARMAT regarding a judicial reorganization procedure (redressement judiciaire) and the subsequent suspension of its stock trading on Euronext. It details the status of a takeover bid and the risks of liquidation. This type of regulatory announcement regarding corporate status, legal proceedings, and trading halts falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually refers to completed or proposed mergers) or legal proceedings (which usually refers to litigation).
2025-08-13 French
Informations privilégiées / Autres communiqués
Share Issue/Capital Change Classification · 1% confidence The document is a formal declaration regarding the total number of voting rights and shares composing the share capital, issued in accordance with Article 223-16 of the AMF General Regulation. This type of disclosure is a standard regulatory requirement for listed companies to inform the market of changes in capital structure and voting rights. It does not represent a new share issuance announcement (SHA) or a transaction in own shares (POS), but rather a periodic disclosure of the current state of the capital. Given it is a regulatory disclosure of share/voting data, it fits best under the RNS (Regulatory Filings) category.
2025-08-11 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.